| scholarly article | Q13442814 |
| P50 | author | Firdausi Qadri | Q16150048 |
| Stephen B Calderwood | Q91760966 | ||
| Edward T Ryan | Q98791672 | ||
| Regina C LaRocque | Q100503624 | ||
| Jason B Harris | Q100503625 | ||
| P2860 | cites work | Antibiotics for both moderate and severe cholera | Q44177512 |
| Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial | Q44235991 | ||
| ABO blood groups and cholera | Q44659524 | ||
| Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis | Q44716334 | ||
| Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru | Q44741357 | ||
| A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India | Q21144301 | ||
| The case for reactive mass oral cholera vaccinations | Q21144515 | ||
| The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa | Q21144553 | ||
| Controlling endemic cholera with oral vaccines | Q21144664 | ||
| Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis | Q21144674 | ||
| DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae | Q22122394 | ||
| Reduced osmolarity oral rehydration solution for treating cholera | Q24245939 | ||
| LPLUNC1 modulates innate immune responses to Vibrio cholerae | Q24337402 | ||
| Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity | Q24536068 | ||
| Reduction of cholera in Bangladeshi villages by simple filtration | Q24598587 | ||
| Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis | Q24611989 | ||
| Host-induced epidemic spread of the cholera bacterium | Q24657125 | ||
| Hyperinfectivity: a critical element in the ability of V. cholerae to cause epidemics? | Q24814721 | ||
| The origin of the Haitian cholera outbreak strain | Q28300132 | ||
| Transmission of Vibrio cholerae is antagonized by lytic phage and entry into the aquatic environment | Q28473809 | ||
| Cholera, diarrhea, and oral rehydration therapy: triumph and indictment | Q30311082 | ||
| Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. | Q30329522 | ||
| Cholera and other types of vibriosis: a story of human pandemics and oysters on the half shell. | Q30333172 | ||
| Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. | Q30349996 | ||
| Comparative genomics reveals mechanism for short-term and long-term clonal transitions in pandemic Vibrio cholerae. | Q30380277 | ||
| The cholera pandemic, still with us after half a century: time to rethink | Q30399168 | ||
| Evidence for several waves of global transmission in the seventh cholera pandemic | Q30406370 | ||
| Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis | Q30418987 | ||
| Comparison of a latex agglutination assay and an enzyme-linked immunosorbent assay for detecting cholera toxin. | Q30421392 | ||
| A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains | Q30429822 | ||
| Vaccination strategies for epidemic cholera in Haiti with implications for the developing world | Q30499938 | ||
| Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area | Q30851263 | ||
| Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh | Q33327386 | ||
| Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh | Q33424453 | ||
| Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis | Q33510195 | ||
| Massive fluid requirements and an unusual BUN/creatinine ratio for pre-renal failure in patients with cholera | Q33512528 | ||
| Transferable quinolone resistance in Vibrio cholerae | Q33613742 | ||
| The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers | Q33768926 | ||
| Severe, acute watery diarrhea in an adult | Q33769896 | ||
| Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplification of phage | Q33771191 | ||
| Use of oral cholera vaccines in an outbreak in Vietnam: a case control study. | Q33808779 | ||
| Concomitant enterotoxigenic Escherichia coli infection induces increased immune responses to Vibrio cholerae O1 antigens in patients with cholera in Bangladesh | Q33826000 | ||
| Amylase-resistant starch plus oral rehydration solution for cholera | Q33888527 | ||
| RAPID IDENTIFICATION OF VIBRIO CHOLERAE BY DARKFIELD MICROSCOPY | Q36912455 | ||
| Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial | Q36953080 | ||
| A novel kit for rapid detection of Vibrio cholerae O1 | Q37070639 | ||
| Bacterial enteropathogens of neonates admitted to an urban diarrhoeal hospital in Bangladesh | Q37289046 | ||
| Cholera transmission: the host, pathogen and bacteriophage dynamic | Q37346626 | ||
| A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh | Q37358603 | ||
| Clinical outcomes in household contacts of patients with cholera in Bangladesh | Q37440466 | ||
| Mechanism of cholera toxin action: Covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system | Q37588093 | ||
| ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase | Q37589612 | ||
| The arrangement of subunits in cholera toxin | Q39080478 | ||
| Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh | Q39415525 | ||
| Field trial of a locally produced, killed, oral cholera vaccine in Vietnam | Q39439547 | ||
| Effectiveness of mass oral cholera vaccination in Beira, Mozambique | Q39708620 | ||
| Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. | Q39708963 | ||
| The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. | Q39821069 | ||
| Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. | Q39830834 | ||
| Use of dipsticks for rapid diagnosis of cholera caused by Vibrio cholerae O1 and O139 from rectal swabs | Q39848571 | ||
| Evaluation and optimization of a latex agglutination assay for detection of cholera toxin and Escherichia coli heat-labile toxin | Q40187647 | ||
| Refractory periods and climate forcing in cholera dynamics | Q40502131 | ||
| Cholera dynamics and El Niño-Southern Oscillation. | Q40749338 | ||
| Hypoglycemia during diarrhea in childhood. Prevalence, pathophysiology, and outcome | Q40762139 | ||
| Global climate and infectious disease: the cholera paradigm | Q41254076 | ||
| A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. | Q41482707 | ||
| Five complementary interventions to slow cholera: Haiti | Q43324142 | ||
| Update: outbreak of cholera ---Haiti, 2010. | Q43324214 | ||
| A lion in our village--the unconscionable tragedy of cholera in Africa | Q43368314 | ||
| Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up | Q45004824 | ||
| Single dose azithromycin versus ciprofloxacin for cholera in children: a randomized controlled trial. | Q45939518 | ||
| Field evaluation of crystal VC Rapid Dipstick test for cholera during a cholera outbreak in Guinea-Bissau | Q46366844 | ||
| Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial | Q46719660 | ||
| A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea | Q46775337 | ||
| An improved technique for isolation of environmental Vibrio cholerae with epidemic potential: monitoring the emergence of a multiple-antibiotic-resistant epidemic strain in Bangladesh | Q46976703 | ||
| Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine | Q50183477 | ||
| Cholera epidemic in Haiti, 2010: using a transmission model to explain spatial spread of disease and identify optimal control interventions. | Q51595260 | ||
| Modeling optimal intervention strategies for cholera. | Q51716506 | ||
| TETRACYCLINE IN THE TREATMENT OF CHOLERA | Q53045013 | ||
| Symptomatic hyponatremia during treatment of dehydrating diarrheal disease with reduced osmolarity oral rehydration solution. | Q53251961 | ||
| Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blind clinical trial. CHOICE study group. | Q53344049 | ||
| Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. | Q53588316 | ||
| Effectiveness of Zinc Supplementation Plus Oral Rehydration Salts Compared With Oral Rehydration Salts Alone as a Treatment for Acute Diarrhea in a Primary Care Setting: A Cluster Randomized Trial | Q53680233 | ||
| Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. | Q54268700 | ||
| Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. | Q54378370 | ||
| Cholera | Q55878773 | ||
| ORAL MAINTENANCE THERAPY FOR CHOLERA IN ADULTS | Q56764907 | ||
| Infectious diseases. Haiti's outbreak is latest in cholera's new global assault | Q57111171 | ||
| Cholera | Q57116811 | ||
| Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139 | Q57923886 | ||
| Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh | Q57924349 | ||
| Impact of B subunit killed whole-cell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera | Q57931243 | ||
| Susceptibility to fluoroquinolones of Vibrio cholerae O1 isolated from diarrheal patients in Zimbabwe | Q57936082 | ||
| Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up | Q57936163 | ||
| Single-dose azithromycin for the treatment of cholera in adults | Q57937510 | ||
| Development and evaluation of a rapid, simple, sensitive, monoclonal antibody-based co-agglutination test for direct detection of Vibrio cholerae 01 | Q57938310 | ||
| Epidemic and endemic cholera trends over a 33-year period in Bangladesh | Q57939849 | ||
| Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam | Q58897746 | ||
| Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994? Goma Epidemiology Group | Q64360985 | ||
| Possible role of blood-group secretory substances in the aetiology of cholera | Q67433050 | ||
| The acidosis of cholera. Contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap | Q69671046 | ||
| Cholera in children | Q70065169 | ||
| Water and electrolyte losses due to cholera in infants and small children: a recovery balance study | Q71501852 | ||
| Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1 | Q71747056 | ||
| Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India | Q72212989 | ||
| Stool electrolyte content and purging rates in diarrhea caused by rotavirus, enterotoxigenic E. coli and V. cholerae in children | Q72891557 | ||
| Evaluation of Peru-15, a new live oral vaccine for cholera, in volunteers | Q73476093 | ||
| Misleading negative findings in a field trial of killed, oral cholera vaccine in Peru | Q73655452 | ||
| Acute renal failure in Asiatic cholera: clinicopathologic correlations with acute tubular necrosis and hypokalemic nephropathy | Q79153211 | ||
| Cholera vaccines: WHO position paper | Q83941810 | ||
| Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial | Q84569360 | ||
| An evaluation of alkaline peptone water for enrichment of Vibrio cholerae in feces | Q93653334 | ||
| Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care | Q33927450 | ||
| Warming oceans, phytoplankton, and river discharge: implications for cholera outbreaks | Q33981104 | ||
| WHO estimates of the causes of death in children | Q33986016 | ||
| Lysogenic conversion by a filamentous phage encoding cholera toxin | Q34062735 | ||
| Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine | Q34121025 | ||
| Responding to cholera in post-earthquake Haiti | Q34153903 | ||
| Survival strategies of bacteria in the natural environment. | Q34173787 | ||
| Predisposition for cholera of individuals with O blood group. Possible evolutionary significance | Q34198861 | ||
| Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. | Q34326253 | ||
| A distinctive class of integron in the Vibrio cholerae genome. | Q34465137 | ||
| A colonization factor links Vibrio cholerae environmental survival and human infection | Q34474848 | ||
| Chitin induces natural competence in Vibrio cholerae | Q34476987 | ||
| The Vibrio cholerae genome contains two unique circular chromosomes. | Q34481163 | ||
| Modeling the role of bacteriophage in the control of cholera outbreaks | Q34574901 | ||
| Transmissibility of cholera: in vivo-formed biofilms and their relationship to infectivity and persistence in the environment | Q34597519 | ||
| Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin | Q34618561 | ||
| The evolutionary history of chromosomal super-integrons provides an ancestry for multiresistant integrons. | Q34624290 | ||
| A variant in long palate, lung and nasal epithelium clone 1 is associated with cholera in a Bangladeshi population | Q34943457 | ||
| Involvement of nicotinamide adenine dinucleotide in the action of cholera toxin in vitro | Q35080637 | ||
| Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents | Q35111201 | ||
| Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004. | Q35112553 | ||
| Transmission dynamics and control of cholera in Haiti: an epidemic model | Q35210763 | ||
| A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. | Q35609627 | ||
| The human, societal, and scientific legacy of cholera. | Q35632324 | ||
| Construction and Evaluation of a Safe, Live, Oral Vibrio cholerae Vaccine Candidate, IEM108 | Q36045133 | ||
| Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea | Q36277234 | ||
| Regulatory networks controlling Vibrio cholerae virulence gene expression | Q36313974 | ||
| Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial | Q36420595 | ||
| An epidemic of cholera due to Vibrio cholerae O139 in Dhaka, Bangladesh: clinical and epidemiological features | Q36504232 | ||
| Live attenuated oral cholera vaccines | Q36600341 | ||
| Cholera's western front | Q36751060 | ||
| Clinical features, antimicrobial susceptibility and toxin production in Vibrio cholerae O139 infection: comparison with V. cholerae O1 infection | Q36828332 | ||
| Antibiotic therapy of cholera in children | Q36910922 | ||
| P433 | issue | 9835 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholera | Q12090 |
| P304 | page(s) | 2466-2476 | |
| P577 | publication date | 2012-06-30 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Cholera | |
| P478 | volume | 379 |
| Q34484003 | A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mic |
| Q30389680 | A Genome-Wide Screen Reveals that the Vibrio cholerae Phosphoenolpyruvate Phosphotransferase System Modulates Virulence Gene Expression |
| Q64094405 | A Human Intestinal Infection Caused by a Novel Non-O1/O139 Genotype and Its Dissemination Along the River |
| Q57171411 | A Systematic Review and Meta-Analysis of the Association between Water, Sanitation, and Hygiene Exposures and Cholera in Case-Control Studies |
| Q35935738 | A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles |
| Q89720418 | A community-wide acute diarrheal disease outbreak associated with drinking contaminated water from shallow bore-wells in a tribal village, India, 2017 |
| Q35989972 | A globally distributed mobile genetic element inhibits natural transformation of Vibrio cholerae |
| Q40489920 | A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes. |
| Q35995440 | A nanocoaxial-based electrochemical sensor for the detection of cholera toxin |
| Q52628040 | ATP-Binding Cassette Transporter VcaM from Vibrio cholerae is Dependent on the Outer Membrane Factor Family for Its Function. |
| Q38376033 | Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era. |
| Q44101270 | Acid-detoxified Inaba lipopolysaccharide (pmLPS) is a superior cholera conjugate vaccine immunogen than hydrazine-detoxified lipopolysaccharide and induces vibriocidal and protective antibodies |
| Q30365868 | Acquisition and evolution of SXT-R391 integrative conjugative elements in the seventh-pandemic Vibrio cholerae lineage. |
| Q26700075 | Advances and Limitations of Disease Biogeography Using Ecological Niche Modeling |
| Q36088345 | An Outbreak of Cholera due to Contaminated Water, Medak District, Andhra Pradesh, India, 2013. |
| Q37261413 | An outbreak of cholera in Medipally village, Andhra Pradesh, India, 2013. |
| Q47556525 | Analysis of Vibrio seventh pandemic island II and novel genomic islands in relation to attachment sequences among a wide variety of Vibrio cholerae strains |
| Q50043320 | Analysis of the Human Mucosal Response to Cholera Reveals Sustained Activation of Innate Immune Signaling Pathways |
| Q30371416 | Anethole inhibits growth of recently emerged multidrug resistant toxigenic Vibrio cholerae O1 El Tor variant strains in vitro. |
| Q52602663 | Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers. |
| Q36053849 | Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults |
| Q37252387 | Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine |
| Q28539765 | Antidiarrheal efficacy and cellular mechanisms of a Thai herbal remedy |
| Q37355150 | Antimicrobial Susceptibility of Autochthonous Aquatic Vibrio cholerae in Haiti |
| Q24193884 | Antimicrobial drugs for treating cholera |
| Q38660838 | Antimicrobial therapy of acute diarrhoea: a clinical review |
| Q51313072 | Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins. |
| Q36185607 | Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children |
| Q40681007 | Blood Group O-Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera. |
| Q40560650 | British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015. |
| Q27679316 | Calcium binding by the PKD1 domain regulates interdomain flexibility inVibrio choleraemetalloprotease PrtV |
| Q92386402 | Capsaicin inhibitory effects on Vibrio cholerae toxin genes expression |
| Q57922508 | Catabolism of mucus components influences motility of Vibrio cholerae in the presence of environmental reservoirs |
| Q38219010 | Challenges in mucosal vaccines for the control of infectious diseases |
| Q30397700 | Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand |
| Q38764395 | Characterization of V. cholerae T3SS-dependent cytotoxicity in cultured intestinal epithelial cells. |
| Q30376966 | Chimeric adaptor proteins translocate diverse type VI secretion system effectors in Vibrio cholerae |
| Q38370138 | Cholera - management and prevention. |
| Q38325644 | Cholera in travelers: shifting tides in epidemiology, management, and prevention |
| Q91719066 | Cholera in travellers: a systematic review |
| Q35232735 | Cholera toxin B: one subunit with many pharmaceutical applications |
| Q35564879 | Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection |
| Q37588131 | Cholera transmission dynamic models for public health practitioners |
| Q35473462 | Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer |
| Q30235247 | Cholera. |
| Q38104753 | Cholera: pathophysiology and emerging therapeutic targets |
| Q34075150 | Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses |
| Q40469281 | Clinical Features of Human Immunodeficiency Virus-Infected Patients Presenting with Cholera in Port-au-Prince, Haiti. |
| Q38264960 | Clinical presentation and management of severe Ebola virus disease |
| Q34580417 | Co- and post-translocation roles for HSP90 in cholera Intoxication |
| Q57093650 | Comparative analyses of CTX prophage region of Vibrio cholerae seventh pandemic wave 1 strains isolated in Asia |
| Q34633653 | Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study |
| Q30372172 | Comparative genome analysis of non-toxigenic non-O1 versus toxigenic O1 Vibrio cholerae. |
| Q39288173 | Comparative genomics study for identification of drug and vaccine targets in Vibrio cholerae: MurA ligase as a case study |
| Q30577797 | Comparing sociocultural features of cholera in three endemic African settings |
| Q34983957 | Concurrent outbreaks of cholera and peripheral neuropathy associated with high mortality among persons internally displaced by a volcanic eruption |
| Q57922421 | Confirmation of cholera by rapid diagnostic test amongst patients admitted to the cholera treatment centre in Uvira, Democratic Republic of the Congo |
| Q34529519 | Cross-Border Cholera Outbreaks in Sub-Saharan Africa, the Mystery behind the Silent Illness: What Needs to Be Done? |
| Q40422208 | Cross-protection against Vibrio cholerae infection by monoclonal antibodies against Vibrio vulnificus RtxA1/MARTXVv |
| Q27702913 | Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae |
| Q57816705 | Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of Enterotoxin |
| Q51783796 | Development of a new dipstick (Cholkit) for rapid detection of Vibrio cholerae O1 in acute watery diarrheal stools. |
| Q41921895 | Development of pVCR94ΔX from Vibrio cholerae, a prototype for studying multidrug resistant IncA/C conjugative plasmids. |
| Q90177287 | Diarrheal correlates associated with enteric bacterial infections among children below five years in Murang'a County, Kenya |
| Q34721830 | Differentially expressed proteins in the skin mucus of Atlantic cod (Gadus morhua) upon natural infection with Vibrio anguillarum |
| Q98224978 | Distribution of hygiene kits during a cholera outbreak in Kasaï-Oriental, Democratic Republic of Congo: a process evaluation |
| Q45022652 | Drug therapy of infectious diarrhea: part 1: acute diarrhea |
| Q52598799 | Dynamics of cholera epidemics from Benin to Mauritania. |
| Q92683836 | Effect of antimicrobial nanocomposites on Vibrio cholerae lifestyles: Pellicle biofilm, planktonic and surface-attached biofilm |
| Q90748647 | Electrospun Carbon Nanofibers as an Electrochemical Immunosensing Platform for Vibrio cholerae Toxin: Aging Effect of the Redox Probe |
| Q90902401 | Emerging outbreaks associated with conflict and failing healthcare systems in the Middle East |
| Q58773623 | Enterohemorrhagic (EHEC)-Secreted Serine Protease EspP Stimulates Electrogenic Ion Transport in Human Colonoid Monolayers |
| Q64118907 | Environmental and Clinical Strains of Non-O1, Non-O139 From Germany Possess Similar Virulence Gene Profiles |
| Q51144560 | Environmental role of pathogenic traits in Vibrio cholerae. |
| Q37482275 | Epidemic cholera spreads like wildfire |
| Q92506600 | Epidemiology of cholera |
| Q41749491 | Estimating the probability of an extinction or major outbreak for an environmentally transmitted infectious disease |
| Q34403586 | Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide |
| Q64896087 | Evaluation of Whole-Genome Sequencing for Identification and Typing of Vibrio cholerae. |
| Q34916897 | Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Vibrio cholerae |
| Q38979270 | Evidence for CVD 103-HgR as an effective single-dose oral cholera vaccine |
| Q36418159 | Factors Related to Fetal Death in Pregnant Women with Cholera, Haiti, 2011-2014 |
| Q40295575 | Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial |
| Q35023661 | First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012. |
| Q35707529 | Fitness cost of antibiotic susceptibility during bacterial infection |
| Q38618320 | From hospitalization records to surveillance: The use of local patient profiles to characterize cholera in Vellore, India |
| Q50143326 | Fucosylated Molecules Competitively Interfere with Cholera Toxin Binding to Host Cells. |
| Q34045324 | Gastroenteritis due to typhoidal Salmonella: a decade of observation at an urban and a rural diarrheal disease hospital in Bangladesh |
| Q55249839 | Genes Activated by Vibrio cholerae upon Exposure to Caenorhabditis elegans Reveal the Mannose-Sensitive Hemagglutinin To Be Essential for Colonization. |
| Q30368300 | Genome Sequence of Vibrio cholerae Strain O1 Ogawa El Tor, Isolated in Mexico, 2013. |
| Q89759494 | Genomic epidemiology of Vibrio cholerae reveals the regional and global spread of two epidemic non-toxigenic lineages |
| Q92340042 | Genomic plasticity associated with antimicrobial resistance in Vibrio cholerae |
| Q28288886 | Global burden of childhood pneumonia and diarrhoea |
| Q57093602 | Glucose metabolism by inhibits intestinal colonization of zebrafish |
| Q91734716 | Health facility preparedness for cholera outbreak response in four cholera-prone districts in Cameroon: a cross sectional study |
| Q38838681 | Host Cell Chaperones Hsp70/Hsp90 and Peptidyl-Prolyl Cis/Trans Isomerases Are Required for the Membrane Translocation of Bacterial ADP-Ribosylating Toxins |
| Q89621207 | Host-Microbe-Pathogen Interactions: A Review of Vibrio cholerae Pathogenesis in Drosophila |
| Q38672464 | Household and Individual Risk Factors for Cholera among Cholera Vaccine Recipients in Rural Haiti |
| Q30902993 | Identifying the most sensitive and specific sign and symptom combinations for cholera: results from an analysis of laboratory-based surveillance data from Haiti, 2012-2013. |
| Q33588522 | Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera |
| Q34334260 | Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh |
| Q37547002 | Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility |
| Q37340450 | Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length |
| Q37572953 | Impact of Ramadan on clinical and microbiologic parameters of patients seen at a diarrheal hospital in urban Dhaka, Bangladesh, 1996-2012. |
| Q40833212 | Imported cholera with acute renal failure after a short business-trip to the Philippines, Germany, October 2015. |
| Q30151668 | Improving immunization approaches to cholera |
| Q41595340 | In vitro and in vivo antimicrobial efficacy of natural plant-derived compounds against Vibrio cholerae of O1 El Tor Inaba serotype |
| Q30390741 | IncA/C Conjugative Plasmids Mobilize a New Family of Multidrug Resistance Islands in Clinical Vibrio cholerae Non-O1/Non-O139 Isolates from Haiti |
| Q92339950 | Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh |
| Q40165092 | Influence of climate factors on Vibrio cholerae dynamics in the Pearl River estuary, South China |
| Q28542764 | Inhibition of cAMP-activated intestinal chloride secretion by diclofenac: cellular mechanism and potential application in cholera |
| Q41426133 | Insights from natural infection-derived immunity to cholera instruct vaccine efforts |
| Q27323928 | Insights into Vibrio cholerae intestinal colonization from monitoring fluorescently labeled bacteria |
| Q34477267 | Intestinal Colonization Dynamics of Vibrio cholerae. |
| Q27027754 | Laboratory diagnosis of bacterial gastroenteritis |
| Q36970778 | Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen. |
| Q47557254 | Long-run effects of early childhood exposure to cholera on final height: Evidence from industrializing Japan |
| Q38697390 | Long-term comparison of antibiotic resistance in Vibrio cholerae O1 and Shigella species between urban and rural Bangladesh |
| Q35197376 | Loperamide therapy for voluminous diarrhea in Ebola virus disease |
| Q35541353 | Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria |
| Q35609312 | Mechanisms of inflammasome activation by Vibrio cholerae secreted toxins vary with strain biotype |
| Q49985266 | Mechanisms of the evolutionary arms race between Vibrio cholerae and Vibriophage clinical isolates |
| Q40936052 | Mesenteric Panniculitis Associated With Vibrio cholerae Infection |
| Q36032331 | Molecular Epidemiology and Antibiotic Susceptibility of Vibrio cholerae Associated with a Large Cholera Outbreak in Ghana in 2014 |
| Q55266491 | Molecular characterization of Vibrio cholerae responsible for cholera epidemics in Uganda by PCR, MLVA and WGS. |
| Q34561393 | Molecular determinants of mechanical properties of V. cholerae biofilms at the air-liquid interface |
| Q35149437 | Multidrug resistant Vibrio cholerae O1 from clinical and environmental samples in Kathmandu city. |
| Q42968701 | Multidrug-resistant IncA/C plasmid in Vibrio cholerae from Haiti |
| Q37016206 | Natural selection and infectious disease in human populations |
| Q34355363 | Natural selection in a bangladeshi population from the cholera-endemic ganges river delta |
| Q36233951 | Non-O1, non-O139 Vibrio cholerae bacteraemia: case report and literature review. |
| Q38229883 | Novel transgenic rice-based vaccines |
| Q36881533 | O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh |
| Q33835587 | OmpU as a biomarker for rapid discrimination between toxigenic and epidemic Vibrio cholerae O1/O139 and non-epidemic Vibrio cholerae in a modified MALDI-TOF MS assay. |
| Q40440951 | Optimized oral cholera vaccine distribution strategies to minimize disease incidence: A mixed integer programming model and analysis of a Bangladesh scenario |
| Q92385552 | Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review |
| Q64130108 | Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh |
| Q30395277 | Origins of the current seventh cholera pandemic |
| Q40052251 | Otitis Media Caused by V. cholerae O100: A Case Report and Review of the Literature |
| Q36267396 | OxyR-activated expression of Dps is important for Vibrio cholerae oxidative stress resistance and pathogenesis |
| Q92677838 | Physiology of Electrolyte Transport in the Gut: Implications for Disease |
| Q41342001 | Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide. |
| Q35933880 | Plasma Leptin Levels in Children Hospitalized with Cholera in Bangladesh |
| Q52717464 | Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh. |
| Q35058572 | Population and genetic study of Vibrio cholerae from the amazon environment confirms that the WASA-1 prophage is the main marker of the epidemic strain that circulated in the region |
| Q64109496 | Post-monsoon waterlogging-associated upsurge of cholera cases in and around Kolkata metropolis, 2015 |
| Q35020391 | Prevalence and characterisation of non-cholerae Vibrio spp. in final effluents of wastewater treatment facilities in two districts of the Eastern Cape Province of South Africa: implications for public health |
| Q92496448 | Prevention and control of cholera with household and community water, sanitation and hygiene (WASH) interventions: A scoping review of current international guidelines |
| Q37711925 | Proteomic analysis of Vibrio cholerae outer membrane vesicles. |
| Q90608796 | Quantifying Vibrio cholerae Colonization and Diarrhea in the Adult Zebrafish Model |
| Q39094295 | Quantitative detection of Vibrio cholera toxin by real-time and dynamic cytotoxicity monitoring. |
| Q37124889 | Quorum sensing regulatory cascades control Vibrio fluvialis pathogenesis |
| Q30628895 | Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology |
| Q43156250 | Re-Emerging Vaccine-Preventable Diseases in War-Affected Peoples of the Eastern Mediterranean Region-An Update |
| Q37345941 | Reduced Susceptibility to Extended-Spectrum β-Lactams in Vibrio cholerae Isolated in Bangladesh |
| Q39883666 | Regulation by ToxR-Like Proteins Converges on vttRB Expression To Control Type 3 Secretion System-Dependent Caco2-BBE Cytotoxicity in Vibrio cholerae. |
| Q37124213 | Role of 6-gingerol in reduction of cholera toxin activity in vitro and in vivo |
| Q54315909 | Role of a TehA homolog in Vibrio cholerae C6706 antibiotic resistance and intestinal colonization. |
| Q46576302 | RpoS is required for natural transformation of Vibrio cholerae through regulation of chitinases |
| Q30356296 | Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera. |
| Q42213440 | Seasonal dynamics of Vibrio cholerae and its phages in riverine ecosystem of Gangetic West Bengal: cholera paradigm |
| Q27009091 | Selected insights from application of whole-genome sequencing for outbreak investigations |
| Q55383107 | Single Circular Chromosome Identified from the Genome Sequence of the Vibrio cholerae O1 bv. El Tor Ogawa Strain V060002. |
| Q35892956 | Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach |
| Q28552894 | Strategies to Prevent Cholera Introduction during International Personnel Deployments: A Computational Modeling Analysis Based on the 2010 Haiti Outbreak |
| Q27681295 | Structural basis for the broad specificity of a new family of amino-acid racemases |
| Q39719231 | Structure of the N-terminal domain of the metalloprotease PrtV from Vibrio cholerae |
| Q28547913 | Suppression of Virulence of Toxigenic Vibrio cholerae by Anethole through the Cyclic AMP (cAMP)-cAMP Receptor Protein Signaling System |
| Q30387610 | Sustained Local Diversity of Vibrio cholerae O1 Biotypes in a Previously Cholera-Free Country |
| Q36702026 | Temperature affects c-di-GMP signalling and biofilm formation in Vibrio cholerae |
| Q31157564 | The 2010 cholera outbreak in Haiti: how science solved a controversy |
| Q36020924 | The Lake Chad Basin, an Isolated and Persistent Reservoir of Vibrio cholerae O1: A Genomic Insight into the Outbreak in Cameroon, 2010. |
| Q46409106 | The Lancet Commission on pollution and health |
| Q37563642 | The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae |
| Q28551039 | The Safety of a Conservative Fluid Replacement Strategy in Adults Hospitalised with Malaria |
| Q28550439 | The Transmission and Antibiotic Resistance Variation in a Multiple Drug Resistance Clade of Vibrio cholerae Circulating in Multiple Countries in Asia |
| Q30370110 | The Vibrio cholerae VprA-VprB two-component system controls virulence through endotoxin modification. |
| Q30619692 | The fluid management of adults with severe malaria |
| Q36338530 | The increased severity in patients presenting to hospital with diarrhea in Dhaka, Bangladesh since the emergence of the hybrid strain of Vibrio cholerae O1 is not unique to cholera patients |
| Q30372674 | The role of China in the global spread of the current cholera pandemic. |
| Q38120924 | The state-of-the-art of approved and under-development cholera vaccines |
| Q38679613 | Towards new cholera prophylactics and treatment: Crystal structures of bacterial enterotoxins in complex with GM1 mimics |
| Q48503396 | Tracking Vibrio cholerae Cell-Cell Interactions during Infection Reveals Bacterial Population Dynamics within Intestinal Microenvironments. |
| Q52668354 | Transmission and Toxigenic Potential of Vibrio cholerae in Hilsha Fish (Tenualosa ilisha) for Human Consumption in Bangladesh. |
| Q35652824 | Updated global burden of cholera in endemic countries |
| Q28354056 | Use of Oral Cholera Vaccine and Knowledge, Attitudes, and Practices Regarding Safe Water, Sanitation and Hygiene in a Long-Standing Refugee Camp, Thailand, 2012-2014 |
| Q90149884 | VX-770-mediated potentiation of numerous human CFTR disease mutants is influenced by phosphorylation level |
| Q27004488 | Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae |
| Q41921695 | Vibrio Pathogens: A Public Health Concern in Rural Water Resources in Sub-Saharan Africa |
| Q40165410 | Vibrio cholerae Colonization of Soft-Shelled Turtles |
| Q92616132 | Vibrio cholerae Infection in Japan Not Associated with Overseas Travel |
| Q37653719 | Vibrio cholerae O1 with Reduced Susceptibility to Ciprofloxacin and Azithromycin Isolated from a Rural Coastal Area of Bangladesh |
| Q36833015 | Vibrio cholerae VttR(A) and VttR(B) regulatory influences extend beyond the type 3 secretion system genomic island |
| Q27333153 | Vibrio cholerae evades neutrophil extracellular traps by the activity of two extracellular nucleases |
| Q47564692 | Vibrio cholerae genomic diversity within and between patients |
| Q52431608 | Vibrio cholerae outer membrane vesicles inhibit bacteriophage infection. |
| Q59239184 | Vibrio cholerae: A historical perspective and current trend |
| Q64096446 | Wave 2 strains of atypical Vibrio cholerae El Tor caused the 2009-2011 cholera outbreak in Papua New Guinea |
| Q37186557 | Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons |
| Q40061810 | Zinc oxide nanoparticles provide anti-cholera activity by disrupting the interaction of cholera toxin with the human GM1 receptor |
| Q40072061 | [Gastrointestinal infections]. |
| Q90664356 | c-di-GMP modulates type IV MSHA pilus retraction and surface attachment in Vibrio cholerae |
Search more.